Abstract
BACKGROUND
Nonadherence to prescription drugs results in poorer control of chronic health conditions. Because of significant racial/ethnic disparities in the control of many chronic diseases, differences in the rates of and reasons for medication nonadherence should be studied.
OBJECTIVES
1) To determine whether rates of and reasons for medication nonadherence vary by race/ethnicity among seniors; and 2) to evaluate whether any association between race/ethnicity and nonadherence is moderated by prescription coverage and income.
DESIGN/SETTING
Cross-sectional national survey, 2003.
PATIENTS
Medicare beneficiaries ≥65 years of age, who reported their race/ethnicity as white, black, or Hispanic, and who reported taking at least 1 medication (n = 14,829).
MAIN OUTCOME MEASURES
Self-reported nonadherence (caused by cost, self-assessed need, or experiences/side effects) during the last 12 months.
RESULTS
Blacks and Hispanics were more likely than whites to report cost-related nonadherence (35.1%, 36.5%, and 26.7%, respectively, p < .001). There were no racial/ethnic differences in nonadherence caused by experiences or self-assessed need. In analyses controlling for age, gender, number of chronic conditions and medications, education, and presence and type of prescription drug coverage, blacks (odds ratio [OR] 1.38; 95% confidence interval [CI] 1.08–1.78) and Hispanics (1.35; 1.02–1.78) remained more likely to report cost-related nonadherence compared to whites. When income was added to the model, the relationship between cost-related nonadherence and race/ethnicity was no longer statistically significant (p = .12).
CONCLUSIONS
Racial/ethnic disparities in medication nonadherence exist among seniors, and are related to cost concerns, and not to differences in experiences or self-assessed need. Considering the importance of medication adherence in controlling chronic diseases, affordability of prescriptions should be explicitly addressed to reduce racial/ethnic disparities.
Similar content being viewed by others
References
Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood) 2005; Suppl Web Exclusives: W5-152-W155-166.
Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med. 2006;166(17):1829–35.
Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292(8):952–60.
Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11(11):730–40.
Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S. The effects of prescription drug copayments on statin adherence. Am J Manag Care. 2006;12(9):509–17.
Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344–50.
Adams AS, Soumerai SB, Ross-Degnan D. The case for a Medicare drug coverage benefit: a critical review of the empirical evidence. Annu Rev Public Health. 2001;22:49–61.
Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27(2):384–91.
Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42(2):102–9.
Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285(4):421–9.
Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42(7):626–34.
Mojtabai R. Medication Costs, Adherence, and Health Outcomes Among Medicare Beneficiaries. Health Aff (Millwood). 2003;22(4):220–9.
Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.
Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61–9.
Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349–59.
Smedley BD, Stith AY, Nelson AR, eds. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, D.C.: National Academy Press; 2003.
Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med. 2005;353(7):692–700.
Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015–21.
Wilson IB, Rogers WH, Chang H, Safran DG. Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study. J Gen Intern Med. 2005;20(8):715–20.
Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94(10):1782–7.
Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16(12):793–9.
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996;86(12):1805–8.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood). 2002;Suppl Web Exclusives:W253–68.
Buck SF. A method of estimation of missing values in multivariate data suitable for use with an electronic computer. J R Stat Soc. 1960;B22:302–6.
Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164(16):1749–55.
Wilson IB, Schoen C, Neuman P, et al. Physician–patient communication about prescription medication nonadherence: a 50-state study of America’s seniors. J Gen Intern Med. 2007;22(1):6–12.
Prescription Drug Coverage Among Medicare Beneficiaries. Menlo Park, CA: The Henry J. Kaiser Family Foundation; June 2006.
Gellad WF, Huskamp HA, Phillips KA, Haas JS. How the new Medicare drug benefit could affect vulnerable populations. Health Aff (Millwood). 2006;25(1):248–55.
Heiss F, McFadden D, Winter J. Who failed to enroll in Medicare part d, and why? Early results. Health Aff (Millwood). 2006;25(5):w344–54.
Rector TS, Venus PJ. Do drug benefits help medicare beneficiaries afford prescribed drugs. Health Aff. 2004;23(4):213–22.
Weingart SN, Gandhi TK, Seger AC, et al. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165(2):234–40.
Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–64.
Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7):649–52.
Acknowledgements
Preparation and production of this manuscript was supported by a National Research Service Award (T32HP11001-18). The design and conduct of the 2003 survey on which these analyses are based was supported by funding from the Commonwealth Fund and the Henry J. Kaiser Family Foundation (KFF) under the direction of Dr. Safran at Tufts-New England Medical Center. Dr. Safran and her team gratefully acknowledge the technical expertise and support provided by Lawrence (Spike) Duzor, Dural Suite, Robyn Thomas of the Centers for Medicare and Medicaid Services (CMS), and Kelly Merriman of ResDAC, without whom the conduct of the survey would not have been possible; and Tricia Neuman and Michelle Kitchman (KFF) and Cathy Schoen (Commonwealth Fund), whose partnership contributed immeasurably to the richness of the survey content and study design. The contents of this paper are the sole responsibility of the authors and do not necessarily represent the views of the Harvard Medical School, Brigham and Women’s Hospital, Tufts-New England Medical Center, or Tufts Medical School.
Conflict of Interest
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gellad, W.F., Haas, J.S. & Safran, D.G. Race/Ethnicity and Nonadherence to Prescription Medications Among Seniors: Results of a National Study. J GEN INTERN MED 22, 1572–1578 (2007). https://doi.org/10.1007/s11606-007-0385-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-007-0385-z